Evidence map›Paper›PMID 24045500›Full record

Trial reportLeukemia2014

Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial.

M Bhutani, B Turkbey, E Tan, T J Kemp, L A Pinto, A R Berg, N Korde, A R Minter, B M Weiss, E Mena and 10 more

Abstract readClinical TrialLetter
In one paragraph

Trial report in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Immunological Prognostic Factors in Multiple Myeloma.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. New Approaches to Molecular Imaging of Multiple Myeloma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

M BhutaniMultiple Myeloma Section, CCR, NCI, NIH, Bethesda, MD, USA.
B TurkbeyMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA.
E TanMultiple Myeloma Section, CCR, NCI, NIH, Bethesda, MD, USA.
T J KempHPV Immunology Laboratory, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
L A PintoHPV Immunology Laboratory, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
A R BergMultiple Myeloma Section, CCR, NCI, NIH, Bethesda, MD, USA.
N KordeMultiple Myeloma Section, CCR, NCI, NIH, Bethesda, MD, USA.
A R MinterMultiple Myeloma Section, CCR, NCI, NIH, Bethesda, MD, USA.
B M WeissMultiple Myeloma Section, CCR, NCI, NIH, Bethesda, MD, USA.
E MenaMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA.
L LindenbergMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA.
O ArasMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA.
M P PurdueDivision of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, MD, USA.
J N HofmannDivision of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, MD, USA.
S M SteinbergBiostatistics and Data Management Section, CCR, NCI, NIH, Bethesda, MD, USA.
K R CalvoHematology Section, CCR, DLM, NIH, Bethesda, MD, USA.
P L ChoykeMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA.
I MaricHematology Section, CCR, DLM, NIH, Bethesda, MD, USA.
K KurdzielMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA.
O LandgrenMultiple Myeloma Section, CCR, NCI, NIH, Bethesda, MD, USA.

Funding

Cancer Risk in Human PopulationsZIACP010136 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI PURDUE, MARK · 2009 to 2025
$36.7M
Intracellular In vivo ImagingZIABC010657 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$20.3M
Office of Collaborative BiostatisticsZIDSC007202 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI CHOO-WOSOBA, HYOYOUNG · 2009 to 2025
$14.5M
CANCER RISK IN HUMAN POPULATIONSZ01CP010136 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SILVERMAN, DEBRA · 1997 to 2008
$5.1M
Angiogenesis imagingZIABC010714 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2015
$4.7M
The Role of microRNA in Hematologic MalignanciesZIACL090025 · CLC · CLINICAL CENTER · PI CALVO, KATHERINE · 2010 to 2025
$0k
Bone Marrow Histopathological Changes in Neoplastic and Non-Neoplastic DiseasesZIACL090027 · CLC · CLINICAL CENTER · PI MARIC, IRINA · 2010 to 2025
$0k
Intramural NIH HHS Z01 CP010136
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neovascularization, PathologicBone MarrowHumansMagnetic Resonance ImagingMonoclonal Gammopathy of Undetermined SignificanceMultiple Myeloma

Identifiers

PMID24045500
PMCPMC6896984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.